Mark Earl Hensley

CIK: 0002065816

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (50.0%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)1 (12.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

HRTX

HERON THERAPEUTICS, INC. /DE/

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

HRTX
HERON THERAPEUTICS, INC. /DE/
Aug 6, 2026
Tax Payment(F)
Direct
8.9K shares at avg. $0.50$4K
HRTX
HERON THERAPEUTICS, INC. /DE/
Aug 6, 2026
Exercise(M)
Direct
31.3K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Jul 31, 2026
Exercise(M)
Direct
11.8K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
May 6, 2026
Exercise(M)
Direct
125K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Apr 30, 2026
Exercise(M)
Direct
11.8K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Jan 30, 2026
Award(A)
Restricted Stock Units
Direct
188.3K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
Jan 30, 2026
Award(A)
Performance Stock Units
Direct
188.3K shares-
HRTX
HERON THERAPEUTICS, INC. /DE/
May 6, 2025
Award(A)
Restricted Stock Units
Direct
500K shares-

		Type	Shares	Price		Ownership
Aug 6, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Tax Payment(F)	8,888	$0.50	$4,444	Direct
Aug 6, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Exercise(M)	31,250	-	$0	Direct
Jul 31, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Exercise(M)	11,769	-	$0	Direct
May 6, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Exercise(M)	125,000	-	$0	Direct
Apr 30, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Exercise(M)	11,770	-	$0	Direct
Jan 30, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Award(A) Restricted Stock Units	188,315	-	-	Direct
Jan 30, 2026	HRTX HERON THERAPEUTICS, INC. /DE/	Award(A) Performance Stock Units	188,314	-	-	Direct
May 6, 2025	HRTX HERON THERAPEUTICS, INC. /DE/	Award(A) Restricted Stock Units	500,000	-	-	Direct

1-8 of 8 transactions

About Hensley Mark Earl

Hensley Mark Earl (SEC CIK 0002065816) files insider reports with the SEC as Chief Operating Officer of HERON THERAPEUTICS, INC. /DE/ (HRTX).

Signal8 holds 8 ownership filings by Hensley Mark Earl (1 Form 3, 7 Form 4), filed between Apr 29, 2025 and Aug 10, 2026. Those filings report 8 transactions, from May 6, 2025 to Aug 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hensley Mark Earl's filings is in CARY, NC.

Recent filings by Hensley Mark Earl

Aug 6, 2026: Tax withholding of HRTX shares (Form 4, code F).
Aug 6, 2026: Option exercise of HRTX shares (Form 4, code M).
Jul 31, 2026: Option exercise of HRTX shares (Form 4, code M).
May 6, 2026: Option exercise of HRTX shares (Form 4, code M).
Apr 30, 2026: Option exercise of HRTX shares (Form 4, code M).

Other insiders filing for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Duarte Ira, EVP, Chief Financial Officer
Forbes William P, EVP, Chief Development Officer
Collard Craig A, Chief Executive Officer
Christian Waage, Director
Kaseta Michael, Director
Johnson Craig A, Director

How to read Form 4 transaction codes